News - Appointments

Philip Bland-Ward becomes CSO at Crescendo Biologics

Philip Bland-Ward

The UK antibody developer Crescendo Biologics Ltd has appointed Philip Bland-Ward as its chief scientific officer to advance the company’s immuno-oncology and drug conjugate programmes to cli

Country: United Kingdom

Read more

Joanne Estell becomes CFO at Shield Therapeutics

Joanne Estell

Joanne Estell, an experienced corporate finance professional, was set to join Shield Therapeutics Plc as chief financial officer and board member on 1 May.

Country: United Kingdom

Read more

Richard Hennings joins Verona Pharma

Richard Hennings

Verona Pharma Plc has announced the appointment of Richard Hennings to the company’s senior management team as commercial director.

Country: United Kingdom

Read more

Timo Veromaa appointed chairman of Domainex

Timo Veromaa

Domainex Ltd, a privately-owned UK drug discovery company, has appointed Timo Veromaa as executive chairman.

Country: United Kingdom

Read more

Takeda promotes Giles Platford

Giles Platford

Giles Platford has been appointed as president of the Europe and Canada business unit of Takeda Pharmaceutical Company Ltd, in addition to his role as a member of the

Country: Switzerland

Read more

Antoine Papiernik appointed chair of Sofinnova

Antoine Papiernik

Antoine Papiernik has become chairman of Sofinnova Partners, marking 20 years with the Paris-based venture capital company.

Country: France

Read more

Garth Cumberlidge becomes chair of Eyevensys

Garth Cumberlidge

Garth Cumberlidge, president and chief executive of Mimetogen Pharmaceuticals Inc, has been appointed chairman of Eyevensys SAS, a biotech company developing therapeu

Country: France

Read more

Adam Stoten named COO at Oxford University Innovation

Adam Stoten

Oxford University Innovation (OUI), the research commercialisation arm of the University of Oxford, has appointed Adam Stoten to the newly created position of chief o

Country: United Kingdom

Read more

Jan Feijen joins Kiadis as COO

Jan Feijen

 Kiadis Pharma NV has appointed Jan Feijen as chief operations officer to help the cell therapy company set up and run a commercial supply chain as its lead prod

Country: Netherlands

Read more

Anne Phelan to head discovery at Mission Therapeutics

Anne Phelan

Anne Phelan has been appointed senior vice president, head of discovery research at Mission Therapeutics Ltd.

Country: United Kingdom

Read more